TECHNOLOGY TRANSFER
Georgia State University’s Office of Technology Licensing & Commercialization works to ensure that great ideas find their way out of the lab and into the hands of the people who need them.

PRECISION MEDCARE
Yi Jiang, Founder & President
Professor, Mathematics and Statistics
YEAR FOUNDED
2017
DEVELOPMENT STATUS
Clinical
FUNDING SUPPORT
Georgia Research Alliance
An Accurate, Non-Invasive Method of Diagnosing Liver Fibrosis
Fibrosis, the formation of scar tissue in the liver, is a manifestation of chronic liver conditions that can eventually modify and interrupt blood flow, causing cirrhosis and impaired organ function. Late-stage fibrosis is irreversible, but the early stages are often asymptomatic, so by the time the disease is detected it’s often too late for intervention.
Available methods of diagnosing fibrosis and cirrhosis can be invasive, expensive, and imprecise. By using Doppler ultrasound scans, a widely available, non-invasive test that measures blood flow, Precision MedCare’s technology can be used in a variety of clinical settings. The algorithm analyzes how blood flow dynamics are impaired by liver rigidity or stiffness, reflecting the condition of the organ as a whole and eliminating the issue of biopsy sampling error. Medical professionals can use the system to diagnose the precise stage of fibrosis with high accuracy. Precision MedCare, LLC, has so far received funding to test the technology in China, where liver diseases affect an estimated 300 million people.
—Yi Jiang
READ MORE
TECHNOLOGY TRANSFER
Georgia State University’s Office of Technology Licensing & Commercialization works to ensure that great ideas find their way out of the lab and into the hands of the people who need them.